Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis

Fairbrother Genevieve; Burigo John; Sharon Thomas; Song Ken

首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis

【24h】

Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis

机译：普通孕妇人群中无细胞DNA胎儿非整倍性的产前筛查：成本效益分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To estimate the cost-effectiveness of fetal aneuploidy screening in the general pregnancy population using non-invasive prenatal testing (NIPT) as compared to first trimester combined screening (FTS) with serum markers and NT ultrasound.

机译：目的：与使用血清标志物和NT超声检查的早孕联合筛查（FTS）相比，使用非侵入性产前检测（NIPT）评估普通妊娠人群胎儿非整倍体筛查的成本效益。

著录项

来源
《The journal of maternal-fetal & neonatal medicine》 |2016年第12期|共5页
作者
Fairbrother Genevieve; Burigo John; Sharon Thomas; Song Ken;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类产科学;
关键词
Cell-free DNA; cost-effectiveness; Down syndrome; non-invasive prenatal testing; prenatal screening;

机译：无细胞DNA;成本效益;唐氏综合症;无创产前检查;产前筛查;

相似文献

外文文献
中文文献
专利

1. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis [J] . Fairbrother Genevieve, Burigo John, Sharon Thomas, The journal of maternal-fetal & neonatal medicine . 2016,第7a12期

机译：普通孕妇人群中无细胞DNA胎儿非整倍性的产前筛查：成本效益分析
2. WellPoint Supports Cell-Free Fetal DNA-Based Prenatal Screening for Fetal Aneuploidy in Certain Pregnancies - Clinical Lab Products [J] . Clinical Lab Products . 2012,第2012期

机译：WellPoint支持对某些妊娠中的胎儿非整倍性进行无细胞胎儿DNA产前筛查-临床实验室产品
3. WellPoint Supports Cell-Free Fetal DNA-Based Prenatal Screening for Fetal Aneuploidy in Certain Pregnancies - Clinical Lab Products [J] . Clinical Lab Products . 2012,第2012期

机译：WellPoint支持对某些妊娠中的胎儿非整倍性进行无细胞胎儿DNA产前筛查-临床实验室产品
4. Cell-Free DNA Prenatal Screen Pipeline for Trisomy and Sex Chromosome Aneuploidy at the Mayo Clinic [C] . Carlos P. Sosa International Molecular Medicine Tri-Conference. . 2019

机译：Mayo诊所的三元和性染色体非细胞非染色体的无细胞DNA产前筛网管道
5. Pushing the Limits of Detection: Investigation of Cell-Free DNA for Aneuploidy Screening in Embryos [D] . Ho, Jacqueline R. 2018

机译：推动检测极限：无细胞DNA用于胚胎非整倍性筛选的研究
6. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis [O] . Genevieve Fairbrother, John Burigo, Thomas Sharon, -1

机译：普通孕妇中无细胞DNA胎儿非整倍体的产前筛查：成本效益分析
7. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis [O] . Genevieve Fairbrother, John Burigo, Thomas Sharon, 2015

机译：胎儿非妊娠人群中无细胞DNA的产前筛选：一种成本效益分析

Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis

摘要

著录项

相似文献

相关主题

期刊订阅